Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer - is interval cytoreductive surgery still needed?
Ovarian cancer patients ≥ 75 years old experience high peri-operative morbidity, but recruitment into prospective trials to assess the role of surgery continues to be challenging.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: David A. Klein, Amandeep K. Mann, Alexandra H. Freeman, Cheng-I. Liao, Daniel S. Kapp, John K. Chan Tags: Original Research: Gynecology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | OBGYN | Ovarian Cancer | Ovaries